LWAM
Legacy Wealth Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,437
| Closed | -$931K | – | 342 |
|
|
2024
Q1 | $931K | Buy |
3,437
+24
| +0.7% | +$6.5K | 0.26% | 109 |
|
|
2023
Q4 | $807K | Buy |
3,413
+19
| +0.6% | +$4.49K | 0.26% | 109 |
|
|
2023
Q3 | $665K | Buy |
3,394
+36
| +1% | +$7.06K | 0.24% | 128 |
|
|
2023
Q2 | $706K | Buy |
3,358
+209
| +7% | +$43.9K | 0.25% | 126 |
|
|
2023
Q1 | $636K | Buy |
3,149
+591
| +23% | +$119K | 0.23% | 147 |
|
|
2022
Q4 | $557K | Buy |
2,558
+342
| +15% | +$74.5K | 0.21% | 161 |
|
|
2022
Q3 | $436K | Buy |
2,216
+999
| +82% | +$197K | 0.19% | 184 |
|
|
2022
Q2 | $260K | Buy |
1,217
+81
| +7% | +$17.3K | 0.11% | 251 |
|
|
2022
Q1 | $323K | Buy |
1,136
+40
| +4% | +$11.4K | 0.12% | 242 |
|
|
2021
Q4 | $413K | Sell |
1,096
-90
| -8% | -$33.9K | 0.14% | 221 |
|
|
2021
Q3 | $489K | Sell |
1,186
-26
| -2% | -$10.7K | 0.22% | 174 |
|
|
2021
Q2 | $448K | Sell |
1,212
-189
| -13% | -$69.9K | 0.2% | 188 |
|
|
2021
Q1 | $406K | Sell |
1,401
-7
| -0.5% | -$2.03K | 0.19% | 202 |
|
|
2020
Q4 | $352K | Buy |
+1,408
| New | +$352K | 0.18% | 212 |
|